Rhythm Pharmaceuticals, Inc. Made Big Gain
Rhythm Pharmaceuticals, Inc. (RYTM:NASDAQ) rocketted at $6.67, a gain of 42.2%. On Tue, Jul 12, 2022, RYTM:NASDAQ touched a New 2-Week High of $6.67. The stock appeared on our News Catalysts scanner on Tue, Jul 12, 2022 at 07:35 AM in the 'BIOTECH' category. From Tue, Jun 28, 2022, the stock recorded 66.67% Up Days and 60.00% Green Days
About Rhythm Pharmaceuticals, Inc. (RYTM:NASDAQ)
Rhythm Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders.
Top 10 Gainers:
- Sharps Compliance Corp. (SMED:NASDAQ), 196.14%
- Canoo Inc. (GOEV:NASDAQ), 53.16%
- Rhythm Pharmaceuticals, Inc. (RYTM:NASDAQ), 42.22%
- Greenwich LifeSciences Inc (GLSI:NASDAQ), 38.98%
- Regional Health Properties, Inc. (RHE:NYSEMKT), 36.88%
- China Online Education Group (COE:NYSE), 32.84%
- Histogen Inc. (HSTO:NASDAQ), 27.46%
- Romeo Power Inc. Class A (RMO:NYSE), 26%
- Lucira Health Inc. (LHDX:NASDAQ), 24.28%
- Aclarion Inc. (ACON:NASDAQ), 22.86%